盤中異動 | 中國有贊再漲近13%,本週累漲近五成,微信公開課再強調視頻號
繼昨日尾盤飆漲13%後,$中國有贊(08083.HK)$早盤再度衝高。截至發稿,漲12.96%,報0.305港元,成交額7640萬港元。
消息面上,在2023微信公開課PRO上,視頻號直播團隊透露,2022年視頻號直播帶貨銷售額同比增長超8倍,其中15%是通過視頻號優選聯盟完成;服飾、視頻、美妝是前三大類目;平臺公域購買轉化率提升超100%,客單價超200元。根據微信公開課的內容,視頻號的發展將圍繞三個方面展開,分別是短視頻、直播和電商。
有贊創始人兼CEO白鴉此前指出,微信視頻號這一新渠道的機會,一方面是巨大的用戶體量;另一方面則是客單價、單個觀看價值、購買轉化率、覆蓋品類等內在指標的良好。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.